Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- JACCRO Established to Promote Clinical Trials for Cancer
April 1, 2002
- BUSINESS NEWS IN BRIEF
April 1, 2002
- RenaScience Offers Renal Disease-Related Genes to Companies
April 1, 2002
- Pele Appointed as Japan's Educational Ambassador for ED: Pfizer
April 1, 2002
- Utilization of Medicinal Plants Reported by Korosho
April 1, 2002
- Bungyo Rate Up 4.8 Points to 45.5%
March 25, 2002
- Revision of Medical Fees to Change Outpatients Visiting Pattern
March 25, 2002
- Cost Calculation Method Needs Improvements: Dr Sugaya of JMA
March 25, 2002
- Operation of Hospitals by Profit-making Organizations Not Recommended
March 25, 2002
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
March 25, 2002
- Speed of Clinical Trials up to 18 Times Slower in Japan: Korosho
March 25, 2002
- Franchise Business GL Proposed by FTC
March 25, 2002
- Around 10% Price Reduction to Have Big Impact on Firms
March 25, 2002
- NID to Develop Product Information System "Drug Store Navi"
March 25, 2002
- Highest Price Reduction Rate Was 78.4%
March 25, 2002
- DIAGNOSTIC NEWS IN BRIEF
March 25, 2002
- BUSINESS NEWS IN BRIEF
March 25, 2002
- MEDICAL DEVICE NEWS IN BRIEF
March 25, 2002
- Nippon Shinyaku Completes Renovation of Production Lines
March 25, 2002
- REGULATORY NEWS IN BRIEF
March 25, 2002
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…